Inventor · disambiguated record
Ubaldo Conte
Also filed as: CONTE UBALDO
25 granted patents·8 pending applications·2,961 citations·filing 1985–2015
98Inventor score
Top patents by PatentIndex Score
33 records- 0197US5738874APharmaceutical tablet capable of liberating one or more drugs at different release ratesJAGOTEC AG·Filed 1993·Granted Apr 14, 1998·276 cites·7 claims
- 0297US5422123ATablets with controlled-rate release of active substancesJAGOTEC AG·Filed 1993·Granted Jun 6, 1995·313 cites·13 claims
- 0397US4839177ASystem for the controlled-rate release of active substancesJAGOTEC AG·Filed 1986·Granted Jun 13, 1989·311 cites·25 claims
- 0496US5780057APharmaceutical tablet characterized by a showing high volume increase when coming into contact with biological fluidsJAGOTEC AG·Filed 1997·Granted Jul 14, 1998·233 cites·17 claims
- 0594US6294200B1Pharmaceutical tablet suitable to deliver the active substance in subsequent and predeterminable timesJAGOTEC AG·Filed 1997·Granted Sep 25, 2001·159 cites·7 claims
- 0694US6027748APharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorptionJAGOTEC AG·Filed 1998·Granted Feb 22, 2000·194 cites·15 claims
- 0793US5464633APharmaceutical tablets releasing the active substance after a definite period of timeJAGOTEC AG·Filed 1994·Granted Nov 7, 1995·151 cites·15 claims
- 0893US4605741APharmaceutically active salt derivative of 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde phosphateLISAPHARMA SPA·Filed 1985·Granted Aug 12, 1986·47 cites·1 claims
- 0992US6183778B1Pharmaceutical tablet capable of liberating one or more drugs at different release ratesJAGOTEC AG·Filed 1998·Granted Feb 6, 2001·189 cites·6 claims
- 1092US6149940ATablet with controlled release of alfuzosine chlorhydrateSYNTHELABO·Filed 1997·Granted Nov 21, 2000·150 cites·23 claims
- 1192US5681583AMultilayered controlled-release oral solid pharmaceutical formsAPPLIED PHARMA RES·Filed 1994·Granted Oct 28, 1997·161 cites·26 claims
- 1292US5650169APharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent timesJAGOTEC AG·Filed 1995·Granted Jul 22, 1997·116 cites·7 claims
- 1391US5594030AControlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acidCT LAB FARM SRL·Filed 1994·Granted Jan 14, 1997·155 cites·12 claims
- 1488US5626874AControlled release pharmaceutical tablet having lenticular formEKITA INVESTMENTS NV·Filed 1994·Granted May 6, 1997·104 cites·6 claims
- 1587US8460706B2Hydrophilic/lipophilic polymeric matrix dosage formulationVERGNAULT GUY·Filed 2011·Granted Jun 11, 2013·8 cites·25 claims
- 1687US5487901AProcess for preparing pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent timesEKITA INVESTMENTS NV·Filed 1994·Granted Jan 30, 1996·90 cites·10 claims
- 1786US4865849ATablet for pharmaceutical use able to release active substances at successive timesPHARMAIDEA SRL·Filed 1987·Granted Sep 12, 1989·97 cites·11 claims
- 1885US7927624B2Hydrophilic/lipophilic polymeric matrix dosage formulationJAGOTEC AG·Filed 2007·Granted Apr 19, 2011·5 cites·35 claims
- 1985US6221395B1Controlled release pharmaceutical tablets containing an active principle of low water solubilityJAGOTEC AG·Filed 1998·Granted Apr 24, 2001·76 cites·4 claims
- 2079US8303986B2Hydrophilic/lipophilic polymeric matrix dosage formulationVERGNAULT GUY·Filed 2009·Granted Nov 6, 2012·2 cites·7 claims
- 2177US4681755ADelivery device for zero-order release of an active principle into a dissolution fluid and process for its preparationSIGMA TAU IND FARMACEUTI·Filed 1985·Granted Jul 21, 1987·54 cites·16 claims
- 2272US5476654AProcess for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtainedJAGOTEC AG·Filed 1994·Granted Dec 19, 1995·37 cites·4 claims
- 2355US5321013APharmaceutical compositions in the form of stable sucralfate suspensions free of suspending agentsLISAPHARMA SPA·Filed 1990·Granted Jun 14, 1994·12 cites·9 claims
- 2452US2005095295A1Therapeutic system for the controlled release of active ingredientsFiled 2003·Application pending·0 cites
- 2552US2005163845A1System for the controlled release of active ingredientsFiled 2003·Application pending·0 cites
- 2650US2003180359A1Hydrophilic/ lipophilic polymeric matrix dosage formulationFiled 2001·Application pending·0 cites
- 2748US5246697AUse of sucralfate humid gel as vehicle for drugs having topic activity and for cosmeticsLISAPHARMA SPA·Filed 1990·Granted Sep 21, 1993·14 cites·3 claims
- 2848US2007196494A1Low-friability, patient-friendly orally disintegrating formulationsGRENIER ARNAUD·Filed 2007·Application pending·0 cites
- 2943US5849329AProcess for preparing pharmaceutical composition having an increased active substance dissolution rate, and the compositions obtainedJAGOTEC AG·Filed 1995·Granted Dec 15, 1998·7 cites·6 claims
- 3041US2009208566A1Capsules Containing Seminal Material for Artificial InseminationVIGO DANIELE·Filed 2006·Application pending·0 cites
- 3141US2007086986A1Preparation of three-dimensional mammalian ovarian follicular cell and ovarin follicle culture systems in a biocompatible matrixVIGO DANIELE·Filed 2004·Application pending·0 cites
- 3238US2009053317A1Microparticulate systems for the oral administration of biologically active substancesVIGO DANIELE·Filed 2006·Application pending·0 cites
- 3337US2017319698A1Gastroretentive gel formulationsJAGOTEC AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ubaldo Conte files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →